Company
United StatesPublic company, NASDAQ: KPTIKaryopharm Therapeutics Inc. (NASDAQ: KPTI), Newton, MA – FDA Inspections
Inspection records and compliance data for Karyopharm Therapeutics Inc. in Newton, Massachusetts. 3 FDA inspections on record, 1 Form 483, last inspected March 15, 2023. Publicly traded as NASDAQ: KPTI.
Company Profile
This profile covers Karyopharm Therapeutics Inc. based in Newton, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected February 8, 2017. Last inspected March 15, 2023.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 15, 2023 | NAI | Human Drugs · Bioresearch Monitoring | 1202243 |
| February 28, 2020 | NAI | Human Drugs · Bioresearch Monitoring | 1122926 |
| February 8, 2017 | VAI | Human Drugs · Bioresearch Monitoring | 1009153 |
FDA documents
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Karyopharm Therapeutics Inc.
Stock ticker
KPTI
Exchange
NASDAQ
Share price
$0.04
Market cap
$907,258
Price as of
November 10, 2026
FEI Number
3012640137
Address
85 Wells Ave Fl 2, Newton, Massachusetts 02459, United States
Country
United States
ID: 28ffa225-b02c-40a0-8662-5bed25336a5a